Discovery of 3‑(4-(2-((1H‑Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)‑1H‑pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease
Article in Journal of Medicinal Chemistry (February 2021)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Journal of Medicinal Chemistry (February 2021)
Article in Autoimmunity Reviews (January 2021)
Article in Arabian Journal of Chemistry (December 2020)